Sharon Binnun sells HRTG shares under 10b5-1
Sharon Binnun reported sales of HRTG common stock under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sharon Binnun reported sales of HRTG common stock under a 10b5-1 plan. The filing shows 9,200 shares sold on 04/01/2026 for $236,589.04 and 7,893 shares sold on 03/17/2026 for $223,750.76. The record also lists 9,200 Restricted Stock Awards dated 03/12/2026.
Insights
Insider executed planned sales via a 10b5-1 arrangement; amounts and dates are disclosed.
The filing lists two 10b5-1 sales by Sharon Binnun: 7,893 shares on 03/17/2026 and 9,200 shares on 04/01/2026, with proceeds displayed in dollars. The schedule also records Restricted Stock Awards dated 03/12/2026.
These entries are routine disclosures of insider transactions and show cash proceeds received by the selling party as listed in the filing. Subsequent filings may show additional transactions or position changes.
Key Figures
Key Terms
Form 144 regulatory
10b5-1 regulatory
Restricted Stock Awards financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were the HRTG sales part of a 10b5-1 plan?
What exchange is referenced for the securities in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.